Intra-nasal vs. Intra-venous Ketamine Administration

The current study wishes to contribute to the applicability of the use of ketamine in a clinical setting by focusing on the efficacy of intra-nasal administration compared with the IV route.

Topic Depression
Compound Placebo Ketamine
Country Israel
Visit trial
Status Completed
Results Published
Start date 04 January 2016
End date 05 January 2020
Chance of happening 100%
Phase Phase IV
Design Blinded
Type Interventional
Generation First
Participants 45
Sex All
Age 18- 65
Therapy No

Trial Details

The current study wishes to contribute to the applicability of the use of ketamine in a clinical setting by focusing on the efficacy of intra-nasal administration compared with the IV route.

NCT Number NCT02644629

Sponsors & Collaborators

Shalvata Mental Health Center
This company doesn't have a full profile yet, it is linked to a clinical trial.

Measures Used

Montgomery-Asberg Depression Rating Scale
A ten-item diagnostic questionnaire used to measure the severity of depressive symptoms in patients with mood disorders.

Data attribution

A large set of the trials in our database are sourced from ClinicalTrials.gov (CTG). We have modified these post to display the information in a more clear format or to correct spelling mistakes. Our database in actively updated and may show a different status (e.g. completed) if we have knowledge of this update (e.g. a published paper on the study) which isn't reflected yet on CTG. If a trial is not sourced from CTG, this is indicated on this page and you can follow the link to the alternative source of information.